Sabine Ruehle, Regulatory Affairs Senior Associate at Boyds, will be presenting at the BIA UK Bioscience Forum 2019 on the 17th October at County Hall in Westminster.
Sabine’s talk on “Bench to bedside: preclinical considerations for advanced therapies” will explore what is needed from the regulatory and safety perspective for the preclinical work to support the administration of ATMPs to humans and how this differs from the requirements of an NCE. The talk will also consider some of the manufacturing aspects particularly relating to the standards of manufacturing required to generate ATMP material to use in the preclinical work.
The talk will be followed by a Q&A session during which, Sabine will be joined by Boyds’ Founder and CEO, Alan Boyd.
The one-day event has a packed and informative programme covering topical industry issues. For more information, click here.